Simply Wall St.
Takeda Pharmaceutical (TSE:4502): Reassessing Valuation After Recent Share Price Strength
📊
AI Sentiment
Positive
7/10
Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of) News
Latest updates and market news for TAK
8 news
Dec 2 - Dec 8, 2025
Page 1
Business Wire
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Protagonist Therapeutics, Inc. (PTGX): A Bull Case Theory
📈
AI Sentiment
Highly Positive
9/10
Pharmaceutical Technology
Takeda and Innovent fulfil close conditions for ADC and IO therapies
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies
📈
AI Sentiment
Highly Positive
8/10
Business Wire
insitro Appoints R&D Veteran Stephen Hitchcock and AI Visionary Vijay Pande as Scientific Advisors
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight
📈
AI Sentiment
Highly Positive
8/10
Share this news page